1. Home
  2. NTSK vs HAE Comparison

NTSK vs HAE Comparison

Compare NTSK & HAE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Netskope Inc.

NTSK

Netskope Inc.

HOLD

Current Price

$24.28

Market Cap

5.9B

Sector

Technology

ML Signal

HOLD

HAE

Haemonetics Corporation

HOLD

Current Price

$118.66

Market Cap

4.8B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
NTSK
HAE
Founded
2012
1971
Country
United States
United States
Employees
N/A
N/A
Industry
Computer Software: Prepackaged Software
Medical/Dental Instruments
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
5.9B
4.8B
IPO Year
2025
1996

Fundamental Metrics

Financial Performance
Metric
NTSK
HAE
Price
$24.28
$118.66
Analyst Decision
Buy
Buy
Analyst Count
18
11
Target Price
$19.36
★ $124.50
AVG Volume (30 Days)
★ 5.4M
607.7K
Earning Date
12-10-2026
11-05-2026
Dividend Yield
N/A
N/A
EPS Growth
★ 12.64
N/A
EPS
N/A
★ 0.72
Revenue
$708,997,000.00
★ $910,373,000.00
Revenue This Year
$25.60
$6.21
Revenue Next Year
$21.14
$5.54
P/E Ratio
★ N/A
$162.15
Revenue Growth
★ 31.72
N/A
52 Week Low
$7.67
$48.98
52 Week High
$24.98
$123.77

Technical Indicators

Market Signals
Indicator
NTSK
HAE
Relative Strength Index (RSI) 74.85 64.22
Support Level $8.67 $100.92
Resistance Level N/A $123.77
Average True Range (ATR) 1.32 3.68
MACD 0.25 -0.20
Stochastic Oscillator 98.91 77.24

Price Performance

Historical Comparison
NTSK
HAE

About NTSK Netskope Inc.

Netskope Inc is redefining the security and networking of cloud and AI. The company has formed a cloud-native platform that offers converged security, networking services, and analytics technology stack to enable fast and secure AI, cloud, and web access at the edge. The products of the company include Netskope One SASE, Netskope One SSE, Cloud Access Security Broker (CASB), Next Generation Secure Web Gateway (SWG), Private Access, Cloud Firewall, SD-WAN, SkopeAI, and others.

About HAE Haemonetics Corporation

Haemonetics Corp aims to improve patient care and reduce the cost of healthcare by providing medical products and solutions in the blood and plasma component collection, surgical suite, and hospital transfusion service spaces. As such, the company operates under three segments: plasma, blood center, and hospital. The Plasma segment includes end-to-end collection technologies, automated plasmapheresis systems (such as the NexSys PCS device), and donor management software designed for commercial plasma collectors. Hospital segment includes Blood Management Technologies (hemostasis analyzers, cell salvage systems) and Interventional Technologies. And the Blood Center provides solutions and devices enabling blood centers to harvest essential components like platelets and red blood cells.

Share on Social Networks: